Sloan Kettering is one of the world’s leading cancer centers. It was founded by two men who created and sold leaded gasoline ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Proceeds from sales at participating 'Miracle in Palm Beach' stores benefit MSK Kids, the pediatric program at Memorial Sloan ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...

Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

A clinical trial at Memorial Sloan Kettering Cancer Center has achieved groundbreaking results in treating rectal cancer using Jemperli.

New York City-based Memorial Sloan Kettering Cancer Center has partnered with Amazon Web Services to accelerate cancer innovation and research through AI, high-performance computing and cloud ...

For instance, AI can examine patient data to predict the likelihood of developing certain diseases and the associated trajectory of disease burden, which allows for early interventions and ...

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...